PARIS (Reuters) – Sanofi said on Tuesday it was working with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Health Department to develop a vaccine against the new coronavirus from China.
The French drugmaker said it intended to further investigate an advanced pre-clinical vaccine candidate previously developed against the SARS virus in the early 2000s, which it believes could protect against the latest coronavirus.
At least a dozen drugmakers are working on vaccines or antivirals and other treatments to help those infected with the fast-spreading contagion.
Johnson & Johnson said last week it was collaborating with BARDA to speed up development of a coronavirus vaccine.
Reporting by Matthias Blamont, Editing by Sarah White
View original article here Source